Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a disease of poor prognosis. The early diagnosis of HCC will restrain the disease progression and thus improve patients’ quality of life. We aimed in this study to define a panel of microRNAs (miRNAs) that could facilitate the early prognosis of HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabbish, Areeg M., Abdelzaher, Hana M., Abohawya, Moustafa, Shamma, Samir, Mahmoud, Yosra H., Maged, Amr, Manaa, Mohamed, Hassany, Mohamed, Kobeissy, Firas, Bazgir, Omid, El-Fawal, Hassan, Azzazy, Hassan M. E., Abdelnaser, Anwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265118/
https://www.ncbi.nlm.nih.gov/pubmed/35804809
http://dx.doi.org/10.3390/cancers14133036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265118/
https://www.ncbi.nlm.nih.gov/pubmed/35804809
http://dx.doi.org/10.3390/cancers14133036

Ejemplares similares